Net lease real estate investment trust (REIT) Agree Realty (ADC 1.39%) has a 4.1% dividend yield. That yield is a little higher than the 3.7% average for the REIT sector, but below the 5.6% you could get from buying industry leading net lease REIT Realty Income.
I have done well over time, but I could have done even better. I have made many mistakes over the years. I discuss 3 of my biggest regrets as a REIT investor.
Initial positive results released from the phase 1b study, using ZYNLONTA + COLUMVI for the treatment of patients with 2nd-line relapsed/refractory DLBCL. Additional results from the phase 1b study, using ZYNLONTA + COLUMVI for the treatment of patients with 2nd-line relapsed/refractory DLBCL, to be released in the 1st half of 2025. The seven major Diffuse Large B-cell Lymphoma markets are expected to reach $5.25 billion by 2034.
REITs are up 40% on average over the past year. But some individual REITs are not up at all. I discuss 2 REITs that remain heavily discounted.
Some dividends are more durable than others. That's due to a combination of the underlying company's financial strength and the resiliency of its business model.
I have outperformed REIT sector averages over the long run. But I could have done even better. I discuss my #1 biggest mistake I have made as a REIT investor.
The U.S. stock market is highly valued, driven by Big Tech and AI investments, with speculative fervor reminiscent of the late 1990s. Some REITs, like W.P. Carey, face challenges due to poor capital allocation and strategic missteps, leading to underperformance compared to tech stocks. Many other REITs, however, have been beaten down due to short-term supply headwinds and their treatment as bond proxies.
The Fed is about to cut interest rates again. We think that this bodes well for REITs. Here are 2 REITs that we are buying ahead of December 18th.
Realty Income offers stable income but lacks recent capital appreciation. Management should focus on share buybacks to drive price appreciation. Diversified portfolio with more than 15,000 properties, but stepping outside core competencies has led to underperformance compared to Agree Realty. Agree Realty's focused strategy on high-quality tenants and U.S.-based retail has resulted in superior returns and growth potential.
This is the first breakthrough therapy designation granted to MRK's sacituzumab tirumotecan in the United States.
GILD and Germany-based Tubulis collaborate to discover and develop an antibody-drug conjugate against a solid tumor target.
Most dividend investors seek solid passive income streams from quality dividend stocks.